- Home
- DAWN vs THCH Comparison
DAWN vs THCH Comparison
Compare DAWN & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- THCH
- Stock Information
- Founded
- DAWN 2018
- THCH 2018
- Country
- DAWN United States
- THCH China
- Employees
- DAWN N/A
- THCH N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- THCH Blank Checks
- Sector
- DAWN Health Care
- THCH Finance
- Exchange
- DAWN Nasdaq
- THCH Nasdaq
- Market Cap
- DAWN 1.3B
- THCH 141.1M
- IPO Year
- DAWN 2021
- THCH N/A
- Fundamental
- Price
- DAWN $12.79
- THCH $0.68
- Analyst Decision
- DAWN Strong Buy
- THCH
- Analyst Count
- DAWN 7
- THCH 0
- Target Price
- DAWN $36.17
- THCH N/A
- AVG Volume (30 Days)
- DAWN 1.0M
- THCH 130.7K
- Earning Date
- DAWN 10-30-2024
- THCH 11-12-2024
- Dividend Yield
- DAWN N/A
- THCH N/A
- EPS Growth
- DAWN N/A
- THCH N/A
- EPS
- DAWN N/A
- THCH N/A
- Revenue
- DAWN $101,953,000.00
- THCH $207,029,179.00
- Revenue This Year
- DAWN N/A
- THCH N/A
- Revenue Next Year
- DAWN $36.10
- THCH N/A
- P/E Ratio
- DAWN N/A
- THCH N/A
- Revenue Growth
- DAWN N/A
- THCH N/A
- 52 Week Low
- DAWN $11.94
- THCH $0.56
- 52 Week High
- DAWN $18.07
- THCH $1.82
- Technical
- Relative Strength Index (RSI)
- DAWN 39.97
- THCH 40.89
- Support Level
- DAWN $12.26
- THCH $0.56
- Resistance Level
- DAWN $12.81
- THCH $0.70
- Average True Range (ATR)
- DAWN 0.52
- THCH 0.09
- MACD
- DAWN -0.05
- THCH -0.02
- Stochastic Oscillator
- DAWN 28.94
- THCH 32.47
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.